Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
SII-ChAdOx1 nCoV-19（COVID-19疫苗）的血清持久性：一项在印度成年人中进行的随机、对照、观察者盲法、II/III期免疫桥接研究的6个月随访结果
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2024.2304974
Kulkarni, Prasad S; Padmapriyadarsini, Chandrasekaran; Vekemans, Johan; Bavdekar, Ashish; Gupta, Madhu; Kulkarni, Praveen; Garg, B S; Gogtay, Nithya J; Tambe, Muralidhar; Lalwani, Sanjay; Singh, Kiranjit; Munshi, Renuka; Meshram, Sushant; Selvavinayagam, T S; Pandey, Krishna; Bhimarasetty, Devi Madhavi; Ramakrishnan, S R; Bhamare, Chetanraj; Dharmadhikari, Abhijeet; Budhawant, Chandrashekhar; Bonhomme, Cyrille J; Thakar, Madhuri; Kurle, Swarali N; Kelly, Elizabeth J; Gautam, Manish; Gupta, Nivedita; Panda, Samiran; Bhargava, Balram; Poonawalla, Cyrus S; Shaligram, Umesh; Kapse, Dhananjay; Gunale, Bhagwat
